CULP H LAWRENCE JR 4

What Happened
Lawrence H. Culp Jr., a director of GE HealthCare Technologies Inc. (GEHC), was awarded a total of 7,743 stock units on May 7, 2026: 3,586 restricted stock units (RSUs) and 4,157 fully vested deferred stock units (DSUs). The Form 4 reports an acquisition price of $0 for these items because they were granted as compensation (not purchased). Each unit represents the right to receive one share of GE HealthCare common stock at settlement.

Key Details

• Transaction date: May 7, 2026 (Form 4 filed May 11, 2026 — timely under the two-business-day rule).
• Units awarded: 3,586 RSUs (F1) and 4,157 DSUs (F3) — total 7,743 units. Reported price: $0 (award).
• Vesting/settlement: F1 RSUs: 100% vest on earlier of the next annual meeting or May 7, 2027; settlement of vested RSUs may be deferred per the director's election under the Plan. F2 clarifies each unit converts to one share at settlement. F3: the 4,157 DSUs were elected in lieu of the cash retainer and are fully vested; settlement follows the reporting person’s deferral election.
• Shares/units owned after transaction: not specified in the filing.
• Filing timeliness: Filed May 11, 2026 for a May 7 transaction — appears timely (within two business days).

Context
These grants are routine director compensation (RSUs/DSUs), not open-market purchases or sales, and are commonly used to compensate non-employee directors. Such awards do not by themselves indicate the director is buying or selling stock in the market; they represent future rights to shares subject to vesting and any deferral elections.